Merck Technology & Imaging Symposium 2023
Breaking boundaries to accelerate a sustainable pipeline.
Our mission is to restore hope by speeding the development of innovative diagnostics and effective treatments to improve care.
We accomplish this by partnering with researchers in industry, academia, and government―furthering their abilities to complete their vital work faster by providing them with the highest quality products and services.
Leverage the world’s largest apheresis donor network to achieve greater speed and reliability across the entire cell and gene therapy, immunological, and oncological continuums from basic discovery through commercialization.
The world’s largest inventory of quality biospecimens with unrivaled selection and characterization.
Discovery is your global strategic partner bringing the know-how, technology, and flexibility to tailor your projects. Genomics, Proteomics, Molecular Pathology, and cell biology services – all under one roof.
Genomic services expertly configured and customized at scale across advanced NGS platforms in one of the largest commercial service laboratories.
Versatile proteomic services conducted by experts to deliver sensitive, reliable, and quantitative results.
Develop clinical trial ready, pathologist-driven IHC/IF assays with over 25 years of experience.
Get biospecimens in the format you need – then deeply characterize with advanced flow cytometry, single cell analysis, and other cell services.
Discovery provides a complete portfolio of ADMET and in vitro preclinical solutions to advance your preclinical studies.
Discovery aids in advancing research programs across many industries. Learn more about how our experts can partner with your organization to drive your research forward.
Discovery Life Sciences Installs World's Largest Commercial Fleet of Novaseq X Plus Systems to Accelerate Genomic Research with Unprecedented Speed and Cost Efficiency
Allcells Expands Apheresis Network to Meet Rapid Growth in Demand for Cell and Gene Therapy Products and Services
Discovery Life Sciences Acquires Reachbio Research Labs
Ready to shorten your project timelines?
Ready to shorten your project timelines?
Breaking boundaries to accelerate a sustainable pipeline.
The ADC Wave Continues Throughout 2023 Accelerate Your Antibody-Drug Conjugate Pipeline to Become a Front-Line Treatment The ADC momentum has continued to dominate the oncology field throughout 2023, with the […]